Skip to main content
Log in

Role of continuous glucose monitoring in the management of glycogen storage disorders

  • Glycogen Storage Disease
  • Published:
Journal of Inherited Metabolic Disease

Abstract

Management of liver glycogen storage diseases (GSDs) primarily involves maintaining normoglycemia through dietary modifications and regular glucose monitoring. Self-monitoring of blood glucose is typically done 3–6 times per day, and may not sufficiently capture periods of asymptomatic hypoglycemia, particularly during sleep. Continuous glucose monitoring systems (CGMS) provide 24-h continuous glucose data and have been used effectively in diabetes mellitus to monitor metabolic control and optimize treatment. This is a relatively new approach in GSDs with only a handful of studies exploring this modality. In this study we used Dexcom CGMS to study the glycemic profile of 14 pediatric and six adult patients with GSD I, III, and IX. A total of 176 days of CGMS data were available. The CGMS was found to be a reliable tool in monitoring glucose levels and trends at all times of the day with good concordance with finger-stick glucose values. This study revealed that in addition to overnight hypoglycemia, CGMS can uncover previously undetected, subclinical, low glucose levels during daytime hours. Additionally, the CGMS detected daytime and overnight hyperglycemia, an often overlooked concern in liver GSDs. The CGMS with concurrent dietary adjustments made by a metabolic dietitian improved metabolic parameters and stabilized blood glucose levels. The CGMS was found to be a safe, effective, and reliable method for optimizing treatment in patients with GSD I, III, and IX.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7
Fig. 8

Similar content being viewed by others

References

  • Aleppo G, Ruedy KJ, Riddlesworth TD, Kruger DF, Peters AL, Hirsch I, Bergenstal RM, Toschi E, Ahmann AJ, Shah VN, Rickels MR, Bode BW, Philis-Tsimikas A, Pop-Busui R, Rodriguez H, Eyth E, Bhargava A, Kollman C, Beck RW, Replace-Bg Study Group (2017) REPLACE-BG: a randomized trial comparing continuous glucose monitoring with and without routine blood glucose monitoring in adults with well-controlled type 1 diabetes. Diabetes Care 40:538–545

    Article  PubMed  PubMed Central  Google Scholar 

  • Allen NA, Fain JA, Braun B, Chipkin SR (2008) Continuous glucose monitoring counseling improves physical activity behaviors of individuals with type 2 diabetes: a randomized clinical trial. Diabetes Res Clin Pract 80:371–379

    Article  PubMed  PubMed Central  Google Scholar 

  • Battelino T, Phillip M, Bratina N, Nimri R, Oskarsson P, Bolinder J (2011) Effect of continuous glucose monitoring on hypoglycemia in type 1 diabetes. Diabetes Care 34:795–800

    Article  PubMed  PubMed Central  Google Scholar 

  • Beck RW, Riddlesworth T, Ruedy K, Ahmann A, Bergenstal R, Haller S, Kollman C, Kruger D, McGill JB, Polonsky W, Toschi E, Wolpert H, Price D, Diamond Study Group (2017) Effect of continuous glucose monitoring on glycemic control in adults with type 1 diabetes using insulin injections: the DIAMOND randomized clinical trial. JAMA 317:371–378

    Article  CAS  PubMed  Google Scholar 

  • Charleer S, Mathieu C, Nobels F, De Block C, Radermecker RP, Hermans MP, Taes Y, Vercammen C, T’Sjoen G, Crenier L, Fieuws S, Keymeulen B, Gillard P (2018) Effect of continuous glucose monitoring on glycemic control, acute admissions, and quality of life: a real-world study. J Clin Endocrinol Metab 103:1224–1232

    Article  PubMed  Google Scholar 

  • Choudhary P, Geddes J, Freeman JV, Emery CJ, Heller SR, Frier BM (2010) Frequency of biochemical hypoglycaemia in adults with type 1 diabetes with and without impaired awareness of hypoglycaemia: no identifiable differences using continuous glucose monitoring. Diabet Med 27:666–672

    Article  CAS  PubMed  Google Scholar 

  • Damiano ER, McKeon K, El-Khatib FH, Zheng H, Nathan DM, Russell SJ (2014) A comparative effectiveness analysis of three continuous glucose monitors: the navigator, G4 platinum, and enlite. J Diabetes Sci Technol 8:699–708

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • FDA (2016) Dexcom G5 Mobile Continuous Glucose Monitoring System. Retrieved from https://www.fda.gov/downloads/AdvisoryCommittees/.../UCM511810.pdf

  • Fonda SJ, Graham C, Munakata J, Powers JM, Price D, Vigersky RA (2016) The cost-effectiveness of real-time continuous glucose monitoring (RT-CGM) in type 2 diabetes. J Diabetes Sci Technol 10:898–904

    Article  PubMed  PubMed Central  Google Scholar 

  • Gold AE, MacLeod KM, Frier BM (1994) Frequency of severe hypoglycemia in patients with type I diabetes with impaired awareness of hypoglycemia. Diabetes Care 17:697–703

    Article  CAS  PubMed  Google Scholar 

  • Hershkovitz E, Rachmel A, Ben-Zaken H, Phillip M (2001) Continuous glucose monitoring in children with glycogen storage disease type I. J Inherit Metab Dis 24:863–869

    Article  CAS  PubMed  Google Scholar 

  • Huang ES, O’Grady M, Basu A, Winn A, John P, Lee J, Meltzer D, Kollman C, Laffel L, Tamborlane W, Weinzimer S, Wysocki T (2010) The cost-effectiveness of continuous glucose monitoring in type 1 diabetes. Diabetes Care 33:1269–1274

    Article  PubMed  PubMed Central  Google Scholar 

  • Jellinger PS (2007) Metabolic consequences of hyperglycemia and insulin resistance. Clin Cornerstone 8(Suppl 7):S30–S42

    Article  PubMed  Google Scholar 

  • Kasapkara CS, Cinasal Demir G, Hasanoglu A, Tumer L (2014) Continuous glucose monitoring in children with glycogen storage disease type I. Eur J Clin Nutr 68:101–105

    Article  CAS  PubMed  Google Scholar 

  • Kishnani PS, Chen YT (2016) Defects in metabolism of carbohydrates. In: Stanton B, Kliegman R, St. Geme J, Schor N, Behrman R (eds) Nelson textbook of pediatrics. Elsevier, Philadelphia

    Google Scholar 

  • Klonoff DC, Ahn D, Drincic A (2017) Continuous glucose monitoring: a review of the technology and clinical use. Diabetes Res Clin Pract 133:178–192

    Article  CAS  PubMed  Google Scholar 

  • Kovatchev BP (2015) Hypoglycemia reduction and accuracy of continuous glucose monitoring. Diabetes Technol Ther 17:530–533

    Article  PubMed  PubMed Central  Google Scholar 

  • Laffel L (2016) Improved accuracy of continuous glucose monitoring systems in pediatric patients with diabetes mellitus: results from two studies. Diabetes Technol Ther 18(Suppl 2):S223–S233

    Article  CAS  PubMed  Google Scholar 

  • Lind M, Polonsky W, Hirsch IB, Heise T, Bolinder J, Dahlqvist S, Schwarz E, Olafsdottir AF, Frid A, Wedel H, Ahlen E, Nystrom T, Hellman J (2017) Continuous glucose monitoring vs conventional therapy for glycemic control in adults with type 1 diabetes treated with multiple daily insulin injections: the GOLD randomized clinical trial. JAMA 317:379–387

    Article  CAS  PubMed  Google Scholar 

  • Mangrola D, Cox C, Furman AS, Krishnan S, Karakas SE (2017) Self-blood glucose monitoring underestimates hyperglycemia and hypoglycemia as compared to continuous glucose monitoring in type 1 and type 2 diabetes. Endocr Pract. https://doi.org/10.4158/EP-2017-0032

  • Maran A, Crepaldi C, Avogaro A, Catuogno S, Burlina A, Poscia A, Tiengo A (2004) Continuous glucose monitoring in conditions other than diabetes. Diabetes Metab Res Rev 20(Suppl 2):S50–S55

    Article  CAS  PubMed  Google Scholar 

  • Martin-Timon I, Del Canizo-Gomez FJ (2015) Mechanisms of hypoglycemia unawareness and implications in diabetic patients. World J Diabetes 6:912–926

    Article  PubMed  PubMed Central  Google Scholar 

  • Nakamura K, Balo A (2015) The accuracy and efficacy of the Dexcom G4 platinum continuous glucose monitoring system. J Diabetes Sci Technol 9:1021–1026

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Oki Y, Okubo M, Tanaka S, Nakanishi K, Kobayashi T, Murase T (2000) Diabetes mellitus secondary to glycogen storage disease type III. Diabet Med 17:810–812

    Article  CAS  PubMed  Google Scholar 

  • Polonsky WH, Hessler D (2013) What are the quality of life-related benefits and losses associated with real-time continuous glucose monitoring? A survey of current users. Diabetes Technol Ther 15:295–301

    Article  PubMed  Google Scholar 

  • Shivers JP, Mackowiak L, Anhalt H, Zisser H (2013) “Turn it off!”: diabetes device alarm fatigue considerations for the present and the future. J Diabetes Sci Technol 7:789–794

    Article  PubMed  PubMed Central  Google Scholar 

  • Spaic T, Driscoll M, Raghinaru D, Buckingham BA, Wilson DM, Clinton P, Chase HP, Maahs DM, Forlenza GP, Jost E, Hramiak I, Paul T, Bequette BW, Cameron F, Beck RW, Kollman C, Lum JW, Ly TT, Group In-Home Closed-Loop Study (2017) Predictive hyperglycemia and hypoglycemia minimization: in-home evaluation of safety, feasibility, and efficacy in overnight glucose control in type 1 diabetes. Diabetes Care 40:359–366

    Article  PubMed  PubMed Central  Google Scholar 

  • Spengos K, Michelakakis H, Vontzalidis A, Zouvelou V, Manta P (2009) Diabetes mellitus associated with glycogen storage disease type III. Muscle Nerve 39:876–877

    Article  PubMed  Google Scholar 

  • Spiegel R, Rakover-Tenenbaum Y, Mandel H, Lumelski D, Admoni O, Horovitz Y (2005) Secondary diabetes mellitus: late complication of glycogen storage disease type 1b. J Pediatr Endocrinol Metab 18:617–619

    Article  PubMed  Google Scholar 

  • American Diabetes Association (2018) Standards of medical care in diabetes—2018; abridged for primary care providers. Clin Diabetes 36:14–37

    Article  PubMed Central  Google Scholar 

  • White FJ, Jones SA (2011) The use of continuous glucose monitoring in the practical management of glycogen storage disorders. J Inherit Metab Dis 34:631–642

    Article  CAS  PubMed  Google Scholar 

  • Yoo HJ, An HG, Park SY, Ryu OH, Kim HY, Seo JA, Hong EG, Shin DH, Kim YH, Kim SG, Choi KM, Park IB, Yu JM, Baik SH (2008) Use of a real time continuous glucose monitoring system as a motivational device for poorly controlled type 2 diabetes. Diabetes Res Clin Pract 82:73–79

    Article  CAS  PubMed  Google Scholar 

Download references

Funding

No external funding sources were used for this study.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Priya S. Kishnani.

Ethics declarations

Conflict of interest

M. Herbert, S. Pendyal, M. Rairikar, C. Halaby, R. W. Benjamin, and P. S. Kishnani declare that they have no conflict of interest.

Animal rights

This article does not contain any studies with human or animal subjects performed by the any of the authors.

Additional information

Communicated by: Terry Derks

Mrudu Herbert and Surekha Pendyal are co-first authors.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Herbert, M., Pendyal, S., Rairikar, M. et al. Role of continuous glucose monitoring in the management of glycogen storage disorders. J Inherit Metab Dis 41, 917–927 (2018). https://doi.org/10.1007/s10545-018-0200-5

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10545-018-0200-5

Navigation